There seems hardly any doubt left that Alzheimer's disease is no less than a medical anomaly for the medical fraternity, but a recent research has revealed a blood test which could possibly tell if the person is going to develop Alzheimer's disease at later stage or not.

This was done by a team at the Eastern University and VTT (Technical Research Centre of Finland), which is told to have said that the test could help in identifying molecular changes and processes in patients with mild cognitive impairment (MCI). This could make one confirm if the person is under the risk of developing Alzheimer's disease or not.

For the research, the team examined 143 people suffering from mild cognitive impairment alongside 46 healthy people and 37 with Alzheimer’s. The team found that those who had MCI were later diagnosed with Alzheimer’s after
31 months. The team had found changes in the blood samples of the sample group and indicated that there are at high risk of being identified with the disease.

With the study hitting the contours of the society, there are fare chances that this test could make intangible part of the treatment so far being adopted for the prediction of Alzheimer's. Published in the journal Translational Psychiatry, the study has once again brought out the underlying theory behind Alzheimer's.

There are as many as over 35,000 people in Ireland who grapple the disease and with the limited treatment in hand, there are efforts required to be made in the same regard. There is need to track out more avenues to find what could be done to resolve the mystery behind Alzheimer's.

“Alzheimer’s Research UK is funding similar studies to understand more about the profiles of metabolites and how they could help us develop new ways to defeat dementia”, said Dr Simon Ridley, Head of Research at Alzheimer’s Research UK.